Sonnet BioTherapeutics Inc (SONN)

[BiotechValues]

Nice. For those who remember the big run back in March...

It began with shares trading just around the rights offering was priced at ($2/share). There were a LOT of naysayers who said management wouldn't get the rights offering completed...they'd fail, etc.

Well management got the offering done and stock doubled over the next 6-8 weeks.

I fully expect the same thing to happen now. Keep in mind it will only take a handful of large investors to complete the offering- these are investors that know the coming acquisition buzz following the rights offering will be good for a big move in the stock. That's how it played out in March and how it will play out now in my opinion.

I'll be updating my subscribers at MicrocapResearch.com with 2 updated articles on HOTR in the next week. Share price has never been better and fundamentals, particularly + EBITDA has never been better.